Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID‐19 pandemic
Efstathios Kastritis, Ashutosh Wechalekar, Stefan Schönland, Vaishali Sanchorawala, Giampaolo Merlini, Giovanni Palladini, Monique C. Minnema, Murielle Roussel, Arnaud Jaccard, Ute Hegenbart, Shaji Kumar, María Teresa Cibeira, Joan Bladé, Meletios A Dimopoulos (2020). Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID‐19 pandemic. , 190(3), DOI: https://doi.org/10.1111/bjh.16898.
Article67 days agoImpact of renal impairment on outcomes with lenalidomide and dexamethasone treatment in the FIRST trial, a randomized, open-label phase 3 trial in transplant-ineligible patients with multiple myeloma
Meletios A Dimopoulos, Matthew C. Cheung, Murielle Roussel, Ting Liu, Barbara Gamberi, Brigitte Kolb, Hans Günter Derigs, Hyeon‐Seok Eom, K. Belhadj, Pascal Lenain, Richard van der Jagt, Sophie Rigaudeau, M. Dib, R. Hall, Henry Jardel, Arnaud Jaccard, Axel Tosikyan, Lionel Karlin, Jack W. Singer, Rik Schots, Nicolas Leupin, G. Chen, J Marek, Annette Ervin‐Haynes, Thierry Façon (2015). Impact of renal impairment on outcomes with lenalidomide and dexamethasone treatment in the FIRST trial, a randomized, open-label phase 3 trial in transplant-ineligible patients with multiple myeloma. , 101(3), DOI: https://doi.org/10.3324/haematol.2015.133629.
Article67 days agoContinuous Lenalidomide and Low-Dose Dexamethasone for the Treatment of Patients with Newly Diagnosed Multiple Myeloma and Renal Impairment in the First Trial
Meletios A Dimopoulos, Matthew C. Cheung, Murielle Roussel, Ting Liu, Barbara Gamberi, Brigitte Kolb, Hans Günter Derigs, Hyeon‐Seok Eom, Karim Belhadj, Pascal Lenain, Richard van der Jagt, Sophie Rigaudeau, R. Hall, Arnaud Jaccard, Axel Tosikyan, Lionel Karlin, Jack W. Singer, Rik Schots, G. Chen, J Marek, Annette Ervin‐Haynes, Thierry Façon (2015). Continuous Lenalidomide and Low-Dose Dexamethasone for the Treatment of Patients with Newly Diagnosed Multiple Myeloma and Renal Impairment in the First Trial. , 15, DOI: https://doi.org/10.1016/j.clml.2015.07.339.
Article67 days agoImpact of Renal Impairment (RI) on Outcomes after Treatment (Tx) with Lenalidomide and Low-Dose Dexamethasone (Rd) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): First Trial Results
Meletios A Dimopoulos, Matthew C. Cheung, Murielle Roussel, Ting Liu, Barbara Gamberi, Brigitte Kolb, Hans Guenter Derigs, Hyeon Seok Eom, Karim Belhadj, Pascal Lenain, Richard H. van der Jagt, Sophie Rigaudeau, Mamoun Dib, R. Hall, Arnaud Jaccard, Axel Tosikyan, Lionel Karlin, William Bensinger, Rik Schots, Guang Chen, Jennifer Marek, Annette Ervin‐Haynes, Thierry Façon (2014). Impact of Renal Impairment (RI) on Outcomes after Treatment (Tx) with Lenalidomide and Low-Dose Dexamethasone (Rd) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): First Trial Results. , 124(21), DOI: https://doi.org/10.1182/blood.v124.21.2112.2112.
Article67 days agoA predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial
Meletios A Dimopoulos, Andrew R. Belch, Angela Dispenzieri, Heinz Ludwig, Philippe Rodon, Jan Van Droogenbroeck, Lugui Qiu, Michèle Cavo, Ann Van de Velde, Juan José Lahuerta, Olivier Allangba, Jae Hoon Lee, Eileen M. Boyle, Aurore Perrot, Philippe Moreau, Salomon Manier, Michel Attal, Murielle Roussel, Mohamad Mohty, Jean Yves Mary, Alexandre Civet, Bruno Costa, Antoine Tinel, Yann Gaston‐Mathé, Thierry Façon, Charles Dumontet, Cyrille Hulin (2018). A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial. , 32(6), DOI: https://doi.org/10.1038/s41375-018-0133-x.
Article67 days ago